Citalopram Hydrobromide Tablet
Product Images NDC 76282-208

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Citalopram Hydrobromide (NDC 76282-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Str)

Chemical structure of citalopram hydrobromide, showing its molecular arrangement with characteristic aromatic rings, a cyano group, a fluorine atom, and the hydrobromide salt component bonded to the amine group.*

FDA Label Image

Image Description (10mg 90 Tablets New)

Label for Citalopram Tablets, USP 10 mg oral tablets from Exelan Pharmaceuticals Inc., containing 90 tablets. The label includes dosage strength, NDC number 76282-628-90, storage instructions, and manufacturer information along with a QR code and lot/expiration placeholders.*

FDA Label Image

Image Description (20mg 90 Tablets New)

Citalopram Tablets USP 20 mg oral tablets, 90 count, labeled by Exelan Pharmaceuticals Inc. The label highlights the strength prominently in a green box and includes handling instructions, manufacturer information, and a barcode. It is intended for human prescription use and must be dispensed with a medication guide.*

FDA Label Image

Image Description (40mg 90 Tablets)

Label for Citalopram Tablets, USP 40 mg oral tablets by Exelan Pharmaceuticals Inc. The package contains 90 tablets. The label includes storage instructions, dosage guidance references, and manufacturer information. It notes the active ingredient as citalopram hydrobromide equivalent to 40 mg of citalopram and indicates Rx only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.